JM Thomas, JL Contreras, CA Smyth, A … - Diabetes, 2001 - Am Diabetes Assoc The recent focus on islet transplantation as primary therapy for type 1 diabetes
has heightened interest in the reversal of type 1 diabetes in preclinical models
using minimal immunosuppression. Here, we demonstrated in a preclinical ... Cited by 65 - Related articles - BL Direct - All 10 versions
JM Thomas, JL Contreras, CA Smyth, A … - DIABETES, 2001 - Am Diabetes Assoc The recent focus on islet transplantation as primary therapy for type 1 diabetes
has heightened interest in the reversal of type 1 diabetes in preclinical models
us- ing minimal immunosuppression. Here, we demonstrat- ed in a preclinical ... Related articles
- ►prsjournal.net JM Thomas, DE Eckhoff, JL Contreras, AL … - Transplantation, 2000 - journals.lww.com Skip Navigation Links Home > June 27, 2000 - Volume 69 - Issue 12 > DURABLE
DONOR-SPECIFIC T AND B CELL TOLERANCE IN RHESUS MACA... ... Thomas, Judith M.;
Eckhoff, Devin E.; Contreras, Juan L.; Lobashevsky, Andrew L.; Hubbard, ... Cited by 71 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org AB Adams, N Shirasugi, MM Durham, E … - Diabetes, 2002 - Am Diabetes Assoc Recent success using a steroid-free immunosuppressive regimen has renewed
enthusiasm for the use of islet transplantation to treat diabetes. Toxicities
associated with the continued use of a calcineurin inhibitor may limit the ... Cited by 98 - Related articles - BL Direct - All 4 versions
WJ Hubbard, JK Moore, JL Contreras, CA … - Human Immunology, 2001 - Elsevier T-cell reduction utilizing specific antibody has been widely used in human
transplantation, and is a cornerstone of several tolerance induction strategies
in nonhuman primates. We have established a population of long-term ... Cited by 19 - Related articles - BL Direct - All 3 versions
JL Contreras, DE Eckhoff, S Cartner, G … - Transplantation, 2000 - ncbi.nlm.nih.gov BACKGROUND: Pancreatic islet transplantation (PIT) is an attractive alternative
for patients with type I diabetes mellitus. PIT is not yet an effective clinical
reality due in part to the high incidence of rejection and early loss of ... Cited by 31 - Related articles - BL Direct - All 2 versions
A Lobashevsky, JP Smith, J Kasten-Jolly, H … - Tissue Antigens, 1999 - interscience.wiley.com Major histocompatibility complex (MHC) class II molecules play a vital role in
the regulation of T-cell functions in the mammalian immune system. Two key
features characterize the polymorphism of MHC haplotypes in humans and ... Cited by 32 - Related articles - BL Direct - All 4 versions
FT Thomas, C Ricordi, JL Contreras, WJ … - Transplantation, 1999 - journals.lww.com Thomas, Francis T.; Ricordi, Camillo; Contreras, Juan L.; Hubbard, William J.;
Jiang, Xiao Ling; Eckhoff, Devin E.; Cartner, Samuel; Bilbao, Guadalupe;
Neville, David M. Jr.; Thomas, Judith M. ... 2 Division of Transplantation ... Cited by 60 - Related articles - BL Direct - All 3 versions
JM Thomas, WJ Hubbard, SK Sooudi, FT … - Immunological reviews, 2001 - interscience.wiley.com Summary: We review a novel strategy for tolerance induction developed in rhesus
macaques and termed STEALTH. We summarize the evolution of the STEALTH model,
the results of successful trials in inducing long-term, stable transplant ... Cited by 26 - Related articles - BL Direct - All 5 versions
